Why this matters — Three distinct ORTEX data types have aligned simultaneously on POET, a rare convergence that follows a 108% weekly price surge in the semiconductor stock. Cost-to-borrow, borrow utilisation, and options sentiment have all moved sharply and in unison over a compressed four-day window.
Cost to Borrow — 587% weekly spike. CTB hit 6.33% on April 24, up from 0.92% on April 17. That is a near sevenfold rise in one week. As recently as April 21, CTB was still below 1.15%. The acceleration — 0.92% → 1.45% → 2.79% → 4.57% → 6.33% across five sessions — signals rapidly tightening borrow supply against a backdrop of intense price action.
Utilisation — Approaching 52-Week High. Utilisation reached 93.96% on April 24, up from 71.0% just one week earlier. The 52-week high stands at 100%. ORTEX factor scores rank POET in the 3rd percentile for utilisation across the universe — meaning nearly all comparable stocks have more borrow slack. With most available shares already on loan, any further short demand has little room to be absorbed.
Options — Put/Call Ratio at 52-Week High. The PCR rose to 0.145 on April 24, a 52-week high and 2.68 standard deviations above the 20-day mean of 0.107. The ratio has climbed steadily since April 20 (0.093). Even at its peak, the absolute PCR remains low in absolute terms — indicating a heavily call-dominated book — but the directional shift is notable given the speed of the move.
Recent insider activity is uniformly negative. Sells were recorded in March 2026 and a cluster in October 2025, with the CFO selling over $4.1M worth of shares across two October trades. Net insider share activity over the trailing 90 days stands at 55,000 shares sold. The most recent analyst price targets (stale, last updated December 2024) top out at $7.00 — well below the current $15.10 close. The stock's ORTEX short score ranks in the 6th percentile — a high short-pressure reading relative to peers.
See the live data behind this article on ORTEX.
Open POET on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
